Meganerv Plus Injection is a parenteral formulation combining Methylcobalamin (1000 mcg), Niacinamide (100 mg), and Vitamin B6 (Pyridoxine, 100 mg), designed to address various neurological and metabolic deficiencies. Methylcobalamin, an active form of Vitamin B12, plays a crucial role in nerve regeneration, DNA synthesis, and hematopoiesis, making it essential for treating peripheral neuropathies and certain anemias. Niacinamide, a derivative of Vitamin B3, contributes to cellular energy production and exhibits neuroprotective properties by enhancing mitochondrial function and reducing oxidative stress. Vitamin B6 (Pyridoxine) is vital for amino acid metabolism, neurotransmitter synthesis, and maintaining normal nerve function. The synergistic combination of these vitamins in Meganerv Plus Injection supports the management of neuropathic pain, diabetic neuropathy, vitamin B deficiencies, and related neurological disorders. This injection is typically administered intramuscularly or intravenously under medical supervision, ensuring rapid bioavailability and therapeutic efficacy. Meganerv Plus is indicated for patients with malabsorption syndromes, chronic alcoholism, or other conditions leading to vitamin B deficiencies. Adverse effects are generally rare but may include mild injection site reactions or hypersensitivity. Proper dosing and administration should be guided by clinical evaluation and laboratory parameters to optimize patient outcomes.